1.) To understand the background of linking gene expression to survival in order to identify new prognostic biomarkers.

2) To understand a web-tool enabling to ling mutation to survival,

3) To get an overview of available datasets including tissue type (normal/cancer), tissue of tumor origin (breast/ovarian/lung/etc), and data type (DNA/mRNA/miRNA



Session date: 
06/05/2017 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Balazs Gyorffy, M.D.,PH.D DSC